Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Effects of Olive Oil on Markers of Inflammation and Endothelial Function-A Systematic Review and Meta-Analysis.

Schwingshackl L, Christoph M, Hoffmann G.

Nutrients. 2015 Sep 11;7(9):7651-75. doi: 10.3390/nu7095356.

2.

Genetic Association Studies Reporting on Variants in the C-Reactive Protein Gene and Coronary Artery Disease: A Meta-Analysis.

Shi Y, Zhang J, Tan C, Xu W, Sun Q, Li J.

Medicine (Baltimore). 2015 Aug;94(32):e1131. doi: 10.1097/MD.0000000000001131.

3.

Mean platelet volume is associated with disease severity in patients with obstructive sleep apnea syndrome.

Akyol S, Çörtük M, Baykan AO, Kiraz K, Börekçi A, Şeker T, Gür M, Çayli M.

Clinics (Sao Paulo). 2015 Jul;70(7):481-5. doi: 10.6061/clinics/2015(07)04. Epub 2015 Jul 1.

4.

Childhood bullying involvement predicts low-grade systemic inflammation into adulthood.

Copeland WE, Wolke D, Lereya ST, Shanahan L, Worthman C, Costello EJ.

Proc Natl Acad Sci U S A. 2014 May 27;111(21):7570-5. doi: 10.1073/pnas.1323641111. Epub 2014 May 12.

5.

C-reactive protein and coronary heart disease: all said--is not it?

Strang F, Schunkert H.

Mediators Inflamm. 2014;2014:757123. doi: 10.1155/2014/757123. Epub 2014 Apr 7. Review.

6.

Evaluation of the Effects of Vaccinium arctostaphylos L. Fruit Extract on Serum Lipids and hs-CRP Levels and Oxidative Stress in Adult Patients with Hyperlipidemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Soltani R, Hakimi M, Asgary S, Ghanadian SM, Keshvari M, Sarrafzadegan N.

Evid Based Complement Alternat Med. 2014;2014:217451. doi: 10.1155/2014/217451. Epub 2014 Jan 23.

7.

Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.

Ferket BS, van Kempen BJ, Hunink MG, Agarwal I, Kavousi M, Franco OH, Steyerberg EW, Max W, Fleischmann KE.

PLoS One. 2014 Feb 18;9(2):e88312. doi: 10.1371/journal.pone.0088312. eCollection 2014.

8.

Self-rated health and C-reactive protein in young adults.

Shanahan L, Bauldry S, Freeman J, Bondy CL.

Brain Behav Immun. 2014 Feb;36:139-46.

9.

C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis.

Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A.

Drug Alcohol Depend. 2013 Dec 1;133(2):712-7. doi: 10.1016/j.drugalcdep.2013.08.027. Epub 2013 Sep 10.

10.

Sex-differentiated changes in C-reactive protein from ages 9 to 21: the contributions of BMI and physical/sexual maturation.

Shanahan L, Copeland WE, Worthman CM, Erkanli A, Angold A, Costello EJ.

Psychoneuroendocrinology. 2013 Oct;38(10):2209-17. doi: 10.1016/j.psyneuen.2013.04.010. Epub 2013 May 25.

11.

Aggregate risk score based on markers of inflammation, cell stress, and coagulation is an independent predictor of adverse cardiovascular outcomes.

Eapen DJ, Manocha P, Patel RS, Hammadah M, Veledar E, Wassel C, Nanjundappa RA, Sikora S, Malayter D, Wilson PW, Sperling L, Quyyumi AA, Epstein SE.

J Am Coll Cardiol. 2013 Jul 23;62(4):329-37. doi: 10.1016/j.jacc.2013.03.072. Epub 2013 May 9.

12.

Prognostic utility of biochemical markers of cardiovascular risk: impact of biological variability.

Alexander KS, Kazmierczak SC, Snyder CK, Oberdorf JA, Farrell DH.

Clin Chem Lab Med. 2013 Sep;51(9):1875-82. doi: 10.1515/cclm-2012-0750.

13.

Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses.

van Holten TC, Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M.

PLoS One. 2013 Apr 22;8(4):e62080. doi: 10.1371/journal.pone.0062080. Print 2013. Review.

14.

Time variability of C-reactive protein: implications for clinical risk stratification.

Bogaty P, Dagenais GR, Joseph L, Boyer L, Leblanc A, Bélisle P, Brophy JM.

PLoS One. 2013 Apr 8;8(4):e60759. doi: 10.1371/journal.pone.0060759. Print 2013.

15.

Metabolic biomarkers for predicting cardiovascular disease.

Montgomery JE, Brown JR.

Vasc Health Risk Manag. 2013;9:37-45. doi: 10.2147/VHRM.S30378. Epub 2013 Jan 29. Review.

16.

Value of C-reactive protein as a risk factor for acute coronary syndrome: a comparison with apolipoprotein concentrations and lipid profile.

Krintus M, Kozinski M, Stefanska A, Sawicki M, Obonska K, Fabiszak T, Kubica J, Sypniewska G.

Mediators Inflamm. 2012;2012:419804. doi: 10.1155/2012/419804. Epub 2012 Oct 16.

17.

Evaluating a New Risk Marker's Predictive Contribution in Survival Models.

Liu M, Kapadia AS, Etzel CJ.

J Stat Theory Pract. 2010 Dec 1;4(4):845-855.

18.

Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis.

Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ.

Psychol Med. 2012 Dec;42(12):2641-50. doi: 10.1017/S0033291712000554. Epub 2012 Apr 30.

19.

Clinical utility of novel biomarkers in the prediction of coronary heart disease.

Kim HC.

Korean Circ J. 2012 Apr;42(4):223-8. doi: 10.4070/kcj.2012.42.4.223. Epub 2012 Apr 26.

20.

Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.

Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE.

Am J Cardiol. 2012 Aug 1;110(3):420-4. doi: 10.1016/j.amjcard.2012.03.044. Epub 2012 Apr 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk